Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,502.00    -48.00 (-3.10%)
Bid:
1,494.00
Ask:
1,498.00
Spread: 4.00 (0.268%)
Market Cap: £783.50m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Directorate Change

24 May 2022 07:00

RNS Number : 4984M
M. P. Evans Group PLC
24 May 2022
 

M.P. EVANS GROUP PLC

("the Group" or "M.P.Evans")

 

DIRECTORATE CHANGE

M.P.Evans Group PLC, a producer of sustainable Indonesian palm oil, announces the following changes to its board of directors.

 

Jock Green-Armytage

 

The board of directors of M.P.Evans ("the board") announces that Jock Green-Armytage, a non-executive director, will be retiring from the board on 30 September 2022. The board wishes to express its gratitude to Jock for his exceptional contribution over his nine-year term as a non-executive, including being the senior independent director and chair of both the audit and remuneration committees. Jock will hand over his responsibilities as senior independent director and chair of committees to Bruce Tozer at the annual general meeting on 9 June 2022.

 

Michael Sherwin

 

The board is pleased to announce the appointment of Michael Sherwin as an independent non-executive director. He joins the board with effect from 1 July 2022. Michael has over 40 years' experience in finance and leadership roles, having originally trained and qualified as a chartered accountant with Price Waterhouse. He was the CFO of Games Workshop plc for ten years during a period of strategic development and expansion, followed by being the CFO at Vertu Motors plc for nine years during a phase of significant acquisition-led growth. In addition, he has worked as non-executive director on several listed boards, including at Plusnet plc where he was appointed on IPO and chaired the audit committee, and at Sumo Group plc where he also was appointed from IPO through to its successful sale in early 2022.

 

As an experienced non-executive director and audit committee representative, Michael recognises the importance of strategic management combined with good governance and a focus on risk management.

 

Peter Hadsley-Chaplin, executive chairman of the Group, said:

 

"We are sorry to be losing Jock's experience from and contribution to the board, both during his current tenure at M.P.Evans and previously at Rowe Evans Investments PLC. His wealth of experience in the sector and in corporate finance has been of great value to the Group. At the same time, we are delighted to be welcoming Michael, and we are confident that his skills and experience in finance and corporate governance will be greatly appreciated in an ever-changing regulatory environment. We look forward to welcoming him in July."

 

 

24 May 2022

 

Enquiries:

M.P. Evans Group PLC

Telephone: 01892 516333

Peter Hadsley-Chaplin - chairman

Matthew Coulson - chief executive

Peel Hunt LLP (Nomad and joint broker)

Telephone: 020 7418 8900

Dan Webster

Andrew Clark

Lalit Bose

finnCap (Joint broker)

Telephone: 020 7220 0500

Tim Redfern

Harriet Ward

Hudson Sandler (Financial PR)

Telephone: 020 7796 4133

Charlie Jack

Elfie Kent

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEXLFLLELEBBZ
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.